BioVie Inc.
BIVI
$1.46
$0.053.55%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -15.51% | -3.80% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.50% | 44.27% | |||
| Operating Income | -18.50% | -44.27% | |||
| Income Before Tax | -19.30% | -45.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -19.30% | -45.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -19.30% | -45.81% | |||
| EBIT | -18.50% | -44.27% | |||
| EBITDA | -18.70% | -44.97% | |||
| EPS Basic | 22.12% | 47.59% | |||
| Normalized Basic EPS | 21.47% | 48.03% | |||
| EPS Diluted | 21.75% | 47.59% | |||
| Normalized Diluted EPS | 21.47% | 48.03% | |||
| Average Basic Shares Outstanding | 51.90% | 180.59% | |||
| Average Diluted Shares Outstanding | 51.90% | 180.59% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||